ArticleThe plant pathology journal2026
Synthesis and Antifungal Evaluation of a Ynone-Tethered 2‑Pyrone Derivative against Phytopathogenic Fungi.
Article in The plant pathology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Numerous fungicides are essential for controlling phytopathogens, enabling modern industrial agriculture to maximize productivity and profitability. However, the extensive use of widely employed fungicides, such as tebuconazole and carbendazim, has led to reduced efficacy due to the emergence of resistant plant-pathogenic fungi. Accordingly, in this study, we synthesized a 2‑pyrone chemotype bearing a ynone substituent, designated as ynone 6 and evaluated its potential as an antifungal scaffold. This representative lead compound exhibited broad-spectrum antifungal activity against five major phytopathogens, including Fusarium graminearum and Botrytis cinerea. Ynone 6 demonstrated potent in planta control efficacy across various host tissues, including wheat spikes, fruits, and leaves, with inhibitory effects comparable to those of tebuconazole. Sensitivity screening using six knockout mutants targeting well-established antifungal pathways revealed that the sensitivity profiles of the mutants differed significantly between conidial germination and hyphal growth, suggesting that the mode of action of ynone 6 is stage-dependent and may involve multiple targets. Collectively, the potent in vitro activity of ynone 6 and its consistent in planta efficacy across multiple host-pathogen systems highlight the ynone-tethered 2-pyrone scaffold as a promising lead scaffold for the development of effective antifungal agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.